Stryker Co. (NYSE:SYK) Shares Purchased by Silvercrest Asset Management Group LLC

Silvercrest Asset Management Group LLC lifted its holdings in Stryker Co. (NYSE:SYK - Free Report) by 0.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 143,957 shares of the medical technology company's stock after purchasing an additional 872 shares during the quarter. Silvercrest Asset Management Group LLC's holdings in Stryker were worth $51,832,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently modified their holdings of the business. Kohmann Bosshard Financial Services LLC bought a new stake in shares of Stryker in the fourth quarter worth $25,000. Rakuten Securities Inc. grew its holdings in shares of Stryker by 618.2% in the fourth quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company's stock worth $28,000 after acquiring an additional 68 shares during the period. Centricity Wealth Management LLC bought a new stake in shares of Stryker in the fourth quarter worth $30,000. BankPlus Trust Department bought a new stake in shares of Stryker in the fourth quarter worth $33,000. Finally, Activest Wealth Management bought a new stake in shares of Stryker in the fourth quarter worth $36,000. Hedge funds and other institutional investors own 77.09% of the company's stock.

Analysts Set New Price Targets

Several brokerages recently commented on SYK. Roth Mkm lifted their price objective on Stryker from $405.00 to $456.00 and gave the stock a "buy" rating in a report on Friday, May 2nd. JPMorgan Chase & Co. lifted their price objective on Stryker from $420.00 to $445.00 and gave the stock an "overweight" rating in a report on Wednesday, January 29th. Barclays lifted their price objective on Stryker from $418.00 to $443.00 and gave the stock an "overweight" rating in a report on Monday, February 10th. Sanford C. Bernstein set a $450.00 price objective on Stryker in a report on Monday, May 5th. Finally, BTIG Research set a $403.00 price target on Stryker and gave the company a "buy" rating in a report on Monday, April 14th. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $427.05.

Insider Transactions at Stryker

In other Stryker news, Director Ronda E. Stryker sold 200,000 shares of the firm's stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the transaction, the director now directly owns 3,417,326 shares in the company, valued at $1,288,195,208.96. This trade represents a 5.53% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Allan C. Golston sold 2,458 shares of the firm's stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $383.07, for a total value of $941,586.06. Following the transaction, the director now owns 14,895 shares in the company, valued at $5,705,827.65. The trade was a 14.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 5.90% of the company's stock.

Stryker Trading Up 0.1%

SYK stock traded up $0.42 during midday trading on Monday, reaching $394.63. 1,072,276 shares of the company traded hands, compared to its average volume of 1,347,466. Stryker Co. has a 52-week low of $314.93 and a 52-week high of $406.19. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.32 and a current ratio of 1.95. The business has a 50 day moving average of $366.62 and a 200-day moving average of $375.61. The firm has a market capitalization of $150.63 billion, a price-to-earnings ratio of 50.85, a P/E/G ratio of 2.93 and a beta of 0.93.

Stryker (NYSE:SYK - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.84 earnings per share for the quarter, topping the consensus estimate of $2.73 by $0.11. Stryker had a return on equity of 23.58% and a net margin of 13.25%. The firm had revenue of $5.87 billion for the quarter, compared to the consensus estimate of $5.68 billion. During the same period in the prior year, the business posted $2.50 earnings per share. The company's revenue for the quarter was up 11.9% on a year-over-year basis. As a group, sell-side analysts expect that Stryker Co. will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, July 31st. Stockholders of record on Monday, June 30th will be issued a $0.84 dividend. The ex-dividend date is Monday, June 30th. This represents a $3.36 annualized dividend and a dividend yield of 0.85%. Stryker's payout ratio is 45.41%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.